MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Immune cell traits and Parkinson’s disease: A Mendelian randomization study

JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang (Hangzhou, China)

Meeting: 2024 International Congress

Abstract Number: 169

Keywords: Parkinson’s

Category: Parkinsonism, Others

Objective: To examine the causal link between peripheral immune cell traits and Parkinson’s disease (PD) risk.

Background: Observational studies have highlighted an association between peripheral immune cells and PD, suggesting potential immunological contributions to the disease pathology.

Method: We conducted a two-sample Mendelian randomization (MR) study using GWAS data to assess the link between immune cell traits and PD risk. This involved a rigorous selection of instrumental variables and was complemented by multivariable Mendelian Randomization (MVMR) analysis and validation in the PD age at onset (AAO) database.

Results: We identified four blood immune-cell-related traits that have a causal effect on PD risk. One trait was found to increase PD risk: CD3 on CD45RA+ CD4+ T cells (odds ratio [OR] and 95% confidence interval [CI] = 1.05 (1.04–1.06), P = 4.38E-28). The other three traits were found to decrease PD risk: 1) the percentage of T lymphocytes predominantly expressing CD45RO+ CD4+ CD25+ CD127hi (OR [95% CI] = 0.93 (0.91–0.95), P = 6.19E-11); 2) CD64 on CD14+ CD16– monocyte (OR [95% CI] = 0.85 (0.79–0.92), P = 4.36E-05); 3) CD64 on monocyte (OR [95% CI] = 0.84 (0.78–0.91), P = 2.08E-05). All the above results passed the Bonferroni correction and all sensitivity tests. Furthermore, these findings were also well validated in MVMR analysis and supported in the PD AAO database.

Conclusion: Our study underscores the correlation between peripheral immune cell traits and the risk of PD, providing insights into the relationship between peripheral immunity and PD.

To cite this abstract in AMA style:

JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang. Immune cell traits and Parkinson’s disease: A Mendelian randomization study [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/immune-cell-traits-and-parkinsons-disease-a-mendelian-randomization-study/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/immune-cell-traits-and-parkinsons-disease-a-mendelian-randomization-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley